Evaluation of efficacy and safety of adjuvant Ayurvedic therapy in patients with severe post-covid mucor-mycosis at a Government tertiary care hospital – A Case-Control study

BACKGROUND: In the wake of the unprecedented Mucormycosis epidemic following the delta variant run second wave of SARS COV-2, the Government of Telangana decided to utilize Ayurveda for its adjuvant immune-boosting role. Based on clinical assessment of patients, Mucor mycosis was identified as Vataj...

Descripción completa

Detalles Bibliográficos
Autores principales: Adluri, Uma Shankar Prasad, Perugu, Srikanthbabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234543/
https://www.ncbi.nlm.nih.gov/pubmed/35772290
http://dx.doi.org/10.1016/j.jaim.2022.100585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234543/
https://www.ncbi.nlm.nih.gov/pubmed/35772290
http://dx.doi.org/10.1016/j.jaim.2022.100585

Ejemplares similares